View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Kathryn hosts one of Ireland’s highest rated TV programmes which helps people to improve their health, lose weight and get fit. As part of the campaign, she will be encouraging pet owners to think about their feeding habits and sharing top dietary tips with over 100,000 followers on her Instagram feed.
John O’Connor MRCVS, Corporate Affairs Director at Royal Canin said: "There are some simple steps pet owners can take to help manage their pet’s weight. For example, measuring cups can lead to pet owners potentially feeding up to 80% more than they should1. Using digital kitchen scales to weigh the food ensures they are feeding their pet exactly the right amount."
John continued, “While it can be hard to resist the temptation to give our pets a little extra treat to show we love them, feeding a dog a rawhide bone could provide them with 67% more calories than they need each day and feeding a cat just 30g of cheese increases their daily energy intake by 60%."
Reference
The work done by vetsurgeon.org and vetnurse.co.uk attempted to identify the sorts of unpleasant behaviour that veterinary surgeons and and nurses found themselves on the receiving end of, and the impact that it had on them. It was not, however, able to quantify the prevalence of these types of behaviour other than to the extent that there were 677 reports.
The new survey of over 650 vet nurses and student vet nurses found that not only did 96% agree or strongly agree that bullying and incivility is a serious problem in the profession, but 70% of respondents had personally experienced a mental health concern as a result.
Other findings from the survey were:
The full findings of the survey will be revealed at the MMI Student Veterinary Nurse Wellbeing Discussion Forum, taking place on Wednesday 3rd November.
Attendees will have the opportunity to discuss the challenges highlighted in the survey and how they can be addressed. The results will also be published at a session led by Jill McDonald, VN Futures Project Coordinator at BVNA Congress, taking place Saturday 2nd – Monday 4th October.
Lisa Quigley, Mind Matters Initiative Manager, said: “A number of our survey findings are extremely concerning, particularly the high levels of bullying, incivility and discrimination reported by participants. We conducted the survey with the intention of finding out more about what systemic issues across workplace practices were impacting on the profession’s mental health.
"We want to thank everyone who took part and shared their experiences with us. There were some upsetting accounts shared with us about experiences of bullying and discrimination – no one should go through this at any point in their life, let alone at their place of work.
"Decisive action needs to be taken to tackle this and we will be using the findings of the survey to help form our 2022-2027 strategy and decide what resources and training we create for the profession. Supporting the wellbeing of veterinary nurses and student veterinary nurses is one of our key priorities, and will be part of all future MMI activities.”
“I would encourage as many veterinary nurses and student veterinary nurses as possible to attend the upcoming Student Veterinary Nurse Wellbeing Discussion Forum and our session at BVNA to have your voice heard about what steps need to be taken to improve the mental wellbeing of the profession.
"We recognise that these results may bring some difficult emotions to the fore for many people, and we would encourage anyone who has experienced bullying or discrimination to seek help from an organisation such as Vetlife or the National Bullying Helpline.
"I would urge anyone who witnesses bullying or discrimination in the workplace to speak out, wherever it is safe to do so. This takes immense courage, but it is only by calling out this behaviour that it can begin to be addressed. We will be launching Active Bystander training in early 2022, to equip people with the confidence to call out unacceptable behaviour, and the skills to proactively support colleagues who have been targeted.”
Matthew Rendle, Chair of the RCVS Veterinary Nurses Council, added: “As a veterinary nurse some of these results were a difficult read and I would like to thank those student vet nurses and newly qualified vet nurses who came forward with great honesty and bravery with their views and experiences, as it couldn’t have been easy.
“We take these matters very seriously and opening up the conversation is an important first step. I hope that, following these results, we can take look at things such as strengthening reporting mechanisms for bullying and discrimination and encouraging better workplace practices to mitigate against these incidents.
“While it’s easy to focus on the negatives, I do think that these survey results have given us positive steps to build on, not least that people know how to access mental health support so they’re not suffering in silence and the role that our amazing clinical coaches are playing in supporting people with their mental health, and how we can better give them the tools for this support.”
Running throughout October, it is Ceva's third TV campaign this year to raise awareness of the benefits of Feliway and Adaptil amongst pet owners.
The campaign starts with a Feliway Classic advertisement running from 3rd October until 16th October, followed by an Adaptil advertisement until 30th October, timed for the run up to the firework season.
The new TV advertising campaign will target 18.5 million pet owners and it will air on all the C4 channels, including Channel 4, E4, More4, Film4, Drama, Good Food, Really, W and Home, with two spots during the popular Channel 4 TV show Great British Bake Off, which has 6.7 million viewers.
The TV advertising campaign will be supported by a Sky Adsmart and social media campaign for ADAPTIL.
Claire Russell, product manager for Feliway and Adaptil at Ceva Animal Health, said: "Our autumn Feliway and Adaptil TV advertising campaign is our biggest, most extensive campaign to date. It demonstrates our commitment to raising awareness of how anxiety in pets can affect the relationship with their owners and how Feliway and Adaptil can help."
For further information, visit www.feliway.com or www.adaptil.com.
Over 25% of the 1001 veterinary professionals who responded felt that the use of technology for triage and or consultations had either improved efficiency or the service offered to clients.
More than 10% said the pandemic had led to practices taking actions which streamlined client processes such as taking payments and booking appointments online or by phone.
The survey results are included in a presentation at the BSAVA Virtual Congress: "Lessons from Lockdown:Telemedicine is here to stay", which forms part of the current topics stream on Saturday 27th March. Brian Faulkner will take a look at maintaining relationships and changing dynamics with remote consults, communication challenges and opportunities. Matt Flann will follow with: "A practical perspective – how we have used it, what have we learned?"
BSAVA President Professor Ian Ramsey said: “The survey results have given us an important insight on how technology is being deployed to help the profession continue to help pets and their owners safely and to the best of their ability in these difficult circumstances.
"Vets have embraced innovations in practice such as telephone triage, remote consultations and digital communications. These have shown us that, as within the human healthcare sector, we can continue to deliver our vital services, possibly to an even more efficient and effective standard, despite the restrictions.
"Our Congress session on lockdown learnings promises to make for compelling listening with important ramifications for veterinary practice even after the pandemic has receded to a bitter memory. As we return to degrees of normality these innovations should not be discarded, but equally must not be allowed to generate the inequalities that go hand in hand with them if some practices and owners are inadvertently left behind.”
To register for BSAVA Congress, visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
What is 'quality improvement', you ask? Good question. Sure, it's an improvement in, er, quality. But of what?
'Quality improvement' is a term adopted from the human healthcare sector, variously defined as anything which makes: "healthcare safer, effective, patient-centred, timely, efficient and equitable (NHS)", or "the combined and unceasing efforts of everyone—healthcare professionals, patients and their families, researchers, payers, planners and educators—to make the changes that will lead to better patient outcomes (health), better system performance (care) and better professional development (BMJ)."
The RCVS research project, which is being conducted by RAND EUROPE, will assess current perceptions and adoption of quality improvement in the veterinary profession.
Specifically, it'll look at the drivers, barriers and expectations associated with QI, with the ultimate goal of strengthening the support provided to the profession.
Chris Gush, Executive Director of RCVS Knowledge, said: "We are delighted to be launching this research project with RAND Europe.
"We know that many of our colleagues across the profession have embedded quality improvement into their practice to great benefit, while we are also aware that it can be a challenge to do so all of the time.
"This research will provide an unprecedented body of evidence on the experiences and perceptions of QI, which will be critical to how we work to support the sector in this area going forward."
Integral to the research is a survey which all members of the profession are invited to take part in, here: bit.ly/QIvetsurvey.
The survey will be live for six weeks, closing early April. It takes around ten minutes to complete, with a prize of one £150 Amazon voucher on offer. Responses will be anonymised.
You can read more about Quality Improvement on the RCVS Knowledge website, here: https://knowledge.rcvs.org.uk/quality-improvement/
Kate’s election means that, come July and subject to ratification by RCVS Council, the offices of RCVS President, Senior-Vice President and Junior Vice-President will all be held by women for the first time in the College’s 177-year history.
A graduate of Edinburgh’s Royal (Dick) School of Veterinary Studies, Kate was a farm vet for 15 years, a partner in a 15 vet practice in Aberdeen. She then moved to the pharmaceutical industry as a veterinary advisor before joining the Department for Environment, Food & Rural Affairs (Defra). From there, she moved into non-veterinary Senior Civil Service (SCS) roles in several Whitehall departments including the Cabinet Office and the Ministry of Justice. As a senior civil servant she was Principal Private Secretary to three Secretaries of State for Scotland, handling a diverse policy portfolio and working across Whitehall, including No.10 Downing Street and the Devolved Administrations.
First elected to RCVS Council in 2015 for a four year term and again in 2020, Kate has previously served as Chair of the RCVS Standards Committee and RCVS representative on the UK co-ordination group for the Federation of Vets of Europe (FVE). Currently Vice Chair of the Education Committee, member of the Registration Committee and the Environment & Sustainability Working Party, Kate is an appointed veterinary member of Veterinary Nurses’ Council.
Kate is a qualified Official Veterinarian (OV), a Non-Executive Director on the Moredun Foundation and Scottish Agriculture College (SAC) Commercial Boards, a veterinary advisor on a Scotland’s Rural College (SRUC) mental health project and on the Council of the Association of Government Veterinarians. She’s a member of the British Veterinary Association (BVA) and the Veterinary Public Health Association. A Council member of the British Cattle Veterinary Association (2004-10), Kate served as a Trustee of the BVA Animal Welfare Foundation (2014-17).
Current RCVS President Dr Mandisa Greene will become Senior Vice-President, and joining Kate and Mandisa on the Officer team will be Dr Melissa Donald, who last month was elected Junior Vice-President for 2021-22. Current Senior Vice-President Dr Niall Connell was recently elected RCVS Treasurer.
The vacancy in the RCVS Officer team arose following Professor David Argyle’s decision to resign from Council in March, meaning that Council needed to hold two votes in quick succession: one at its scheduled meeting in March for the 2021-22 JVP position; and one today for the current JVP vacancy.
Kate said: “I am delighted to be elected JVP. It’s been an exceptionally challenging year for those in all walks of veterinary life, including students aspiring to join our profession. It will be an honour to lead the RCVS as its tenth female president, working with veterinary colleagues as well as reaching out to allied professionals acknowledging that there will be challenges to navigate as well as triumphs to celebrate.”
Ear cropping in UK dogs was exposed by BBC’s Panorama as a growing problem particularly with extreme mix breeds such as American Bullies and XL Bullies.
Dave said: “We need to urgently relook at legislation in the UK to prevent the serious rise in ear cropping which we’ve witnessed in recent years.”
It is currently illegal for a dog’s ears to be cropped in the UK, and proposals for a ban on importing dogs with cropped ears have been put forward by the Government. However, Dave says this legislation doesn’t go far enough to prevent an exponential rise in dogs with cropped ears, which some owners see as a status symbol: “At the moment the legislation in the UK is very hard to enforce unless you actually catch someone in the act of cropping the dog’s ears.
“It’s not currently illegal for someone to own a dog with cropped ears.
"So, if an owner were challenged by enforcement agencies, they’d just say ‘I bought the dog like this’ and there’s no liability.” “We propose that any dogs who already have cropped ears at the time the ban is due to come into force, must be registered on a database, which enforcement agencies and the veterinary profession would have access to.
"And for anyone owning an unregistered dog with cropped ears after the legislation comes into effect, then it’s a criminal offence.”
The Panorama programme also exposed co-ownership – where the breeder and the pet owner share ownership of the dog, often the bitch – as a system which has enabled unscrupulous breeders to get around current laws on dog breeding in the UK.
The breeder retains ownership of the stud dog and uses the network of co-owned female dogs for reproduction purposes. Dave said: “People need to be made aware of the risks of entering into a legal contract as a co-owner of one of these extreme mix breed dogs. “All the contracts I have seen in my role as an expert witness are strongly weighed in favour of the breeder. “So for example if the bitch does not have the requisite number of litters, or becomes ill or injured and has to be put to sleep, then the co-owner is fully liable for the full purchase cost of the dog to the breeder. “Considering that the female dogs are often valued in excess of £12k and the breeder may well have connections to organised crime or have a criminal record, there are huge risks for people entering into co-ownership.”
whatstherisk.co.uk has been created for all practice staff and contains advice from parasitologists Ian Wright and Eric Morgan.
Topics include advice on practical risk assessments, how risk-based prescribing can work with health plans as well as how to get owners involved to make risk assessment and personalised prescribing quicker and simpler.
Boehringer says that all the materials and advice have been developed in line with RCVS Practice Standards and the BVA's guidance on the responsible use of parasiticides.1,2
Sharron Woods, NexGard brands Franchise Manager said: “With knowledge about parasitic risk low among dog owners, alongside increasing scrutiny on the potential overuse of parasiticides, we’re delighted to be at the forefront of supporting vets, pet owners and the wider industry in driving best-practice risk assessment and responsible parasite control."
References
The company says it's not just older horses suffering from joint disease, 36% of horses developed the condition by the time they were eight years old.
In the survey, 69% of horses needed up to five visits to their veterinary surgeon for treatment, while 21% needed as many as ten visits. Horse owners spent an average of £2,104 treating their horse’s joint condition while 5% spent more than £7,500 on the problem.
In addition, 53% said they've missed up to ten competitions due to joint disease, with 17% missing more than 20 competitions.
The survey revealed that joint problems are an ongoing concern for many. 76% of owners said they worry about their horse developing osteoarthritis and 30% had retired a horse earlier than expected owing to joint disease. In addition, 84% admitted that they would not buy a horse if they knew it had joint problems.
In terms of joint care, 74% of respondents said they give their horse a joint supplement. 69% check their horse's legs daily and 90% implement post-competition leg care measures.
Cavalor’s Lieselot Hamerlinck said: "It is good to see that so many horse owners are using a joint supplement but it’s important that they understand what to look for when choosing which product to use. They should look for anti-inflammatory products, not just joint support and for clinical evidence on any product claims. It’s not just about giving a joint supplement every day, it’s more about giving the right product tailored to the horse’s individual needs.
"Also horse owners should be mindful that it is equally important, if not more so, to take proper care of their horse’s joints all year round, not just during competition."
For further information, visit www.cavalor.com.
RCVS CEO Nick Stace has published a refreshingly candid acknowledgement of recent concerns voiced by the profession on his blog, www.nickstaceblogs.org.
In his post, he gives a firm commitment to listen to the profession, asking just that in return, MsRCVS get more involved in College matters, such as voting in the elections and getting involved in consultations (starting with this one).
Definitely worth reading the full post: http://nickstaceblogs.org/2014/05/06/receiving-you-loud-and-clear/
The report, which was developed in consultation with BVA members, devolved branches, BVA specialist divisions and other stakeholders, outlines the essential role that the UK veterinary workforce plays in not only caring for animals, but in enabling trade, ensuring food hygiene and safety, and undertaking cutting-edge research.
Non-British EU veterinary surgeons are critical to the UK veterinary workforce. Around 50% of veterinary surgeons registering to practise in the UK each year come from overseas, with the vast majority of these coming from the rest of the EU. Yet one-fifth of vets are already reporting that it has become harder to recruit since the EU Referendum.
To secure the best possible outcomes for animal health and welfare, public health, and the veterinary profession, Brexit and the veterinary profession sets out 52 recommendations for the short, medium and long term, including calling on the next Government to:
BVA President Gudrun Ravetz said: "Vets provide the foundation for the UK’s work on animal health and welfare. Veterinary teams up and down the country support the UK’s 11 million pet-owning households; not a penny of the UK’s £13 billion agri-food industry could be realised without vets; and we are an integral part of the international scientific community, annually bringing in over £50 million for research and development projects.
"The veterinary profession is in a unique position from which to offer the next Government evidence-based policy recommendations to ensure animal health and welfare, public health and other standards are at the very least maintained as we exit the EU.
"We believe Brexit also presents us with opportunities, for example, to develop a strong, competitive food industry with full consumer confidence at home and abroad as well as to position the UK as a world leader in high animal welfare - and a strong veterinary workforce is vital in achieving this."
Brexit and the veterinary profession was developed and written by the BVA Brexit Working Group, under the chairmanship of Alick Simmons, former UK deputy Chief Veterinary Officer, and was agreed by BVA Council in April.
The report builds on BVA’s Brexit Principles, agreed by Council in September 2016, and covers seven areas of public policy: veterinary workforce, animal health, animal welfare, food hygiene and safety, veterinary medicines, research and development, and trade.
Two further sections of the report consider issues relating to devolution and to Northern Ireland’s unique position as the only part of the UK to share a land border with an EU member state.
With a snap General Election due in five weeks’ time, BVA has produced a 20-point manifesto of key recommendations covering both Brexit and wider policy issues, which has been sent to the main political parties’ manifesto-writing teams and to BVA’s Honorary Associates.
Brexit and the veterinary profession and the manifesto for the 2017 General Election are available at: www.bva.co.uk/brexit.
Merial has highlighted two new studies which the company says demonstrates the efficacy and safety of its canine NSAID, Previcox.
In the first study, Lecoindre and Pepin evaluated the beneficial effects of once daily administration of 5mg/kg Previcox to dogs suffering from osteoarthritis (OA) for 90 days. According to the company, response to treatment was excellent, with significant improvements observed in lameness scores, pain on manipulation of the affected joint and range of motion. Of particular note was the fact that the degree of improvement increased with duration of treatment, clearly demonstrating the benefits of longer term treatment. These results support the findings of a recent review of the safety and efficacy of long-term NSAID use in dogs with OA. The product's safety profile was also evaluated by means of biochemistry and haematology assessments. In addition, regular gastroscopic examinations were used to directly visualise the effect of treatment on the gastric mucosa. These safety assessments demonstrated that Previcox therapy was well tolerated, with no significant treatment related changes seen on biochemistry or gastroscopy, despite the fact that this was a geriatric population which included a number of dogs with a prior history of gastrointestinal tract disease.
Merials says the findings from a different study by Joubert, published in the South African Veterinary Journal, provide further confirmation of the beneficial effects of 90 days Previcox treatment in a geriatric population of dogs.
Commenting on the results of the two studies, Kevin Whelan, Merial's Veterinary Technical Manager said: "The outcome from these studies provide further evidence for the benefits of long term use of Previcox in dogs suffering from osteoarthritis. There is relatively little published information available on the use of NSAIDs in older dogs, and these results confirm that Previcox is well tolerated in this group of patients."
For further information about Previcox, please contact your local Territory Manager or call 0870 6000 123.
References:
Dr Mostert admitted to his conviction but denied that it rendered him unfit to practise as a veterinary surgeon.
He also admitted not disclosing his conviction to the RCVS but denied that it amounted to dishonesty or was misleading and that failing to do so amounted to disgraceful conduct in a professional respect.
The Committee first considered whether Dr Mostert’s conviction affected the public interest, which included the need to maintain public confidence in the profession by upholding proper standards of conduct and behaviour for members of the profession.
The Committee noted that the conviction involved dishonesty relating to false statements about the value of goods sent to the USA.
The Committee felt that a conviction for a serious offence involving dishonesty would have a negative impact on public confidence in the profession, and that its reputation would be damaged if proper standards of conduct and behaviour were not upheld.
The Committee also noted that as the products that Dr Mostert imported into the USA were not labelled as coming from a foreign market and were not labelled as needing to be administered by a vet, his conviction also related to animal safety, as anyone who accessed the medications could believe that it was safe for them to be given to an animal.
The Committee then considered Dr Mostert’s failure to declare the conviction to the College on three separate occasions.
Dr Mostert testified that, at the time, he did not believe he had to disclose his conviction as it occurred in a country where he had not practised as a veterinary surgeon.
He also said he had not taken the time to read and interpret the application form accurately.
However, the Committee considered that the wording around convictions on the application and annual renewal forms is very clear and that, as a veterinary surgeon, Dr Mostert would be familiar with such documents.
The Committee considered that it was inconceivable that an experienced veterinary surgeon, making a declaration of this kind to his regulator, would not have understood that a serious conviction in the USA, dating from June 2017, was a conviction that he was obliged to disclose.
The Committee therefore found Dr Mostert’s failures to declare his conviction dishonest.
Judith Way, Chairing the Committee and speaking on its behalf, noted that in deciding upon the appropriate sanction, the case did not involve any actual harm to an animal or human and that Dr Mostert had had a long and otherwise unblemished career.
However, a key aggravating factor was that the action that led to the conviction resulted in financial gain through the creation of a business enterprise and that Dr Mostert falsely declared the value of goods.
The extent of any financial gain was not known to the Committee, but the business operated on the basis that false declarations were repeatedly made.
Judith said: “After careful consideration the Committee has concluded that in all the circumstances, a lengthy period of suspension would properly reflect the gravity of the case and satisfy the public interest. The Committee has decided that the appropriate length of suspension is one of 18 months.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
At the hearing, the Disciplinary Committee considered whether she had accepted the findings of the Committee at the original inquiry hearing, the seriousness of those findings, whether she had demonstrated insight into her past conduct, and the protection of the public and the public interest.
In her restoration application, Dr Burrows included continuing professional development (CPD) certificates for the courses she had completed since her removal from the Register, letters/informal witness statements from the veterinary surgeons and nurses she had worked who had expressed a willingness to employ her again, together with character references and reflection statements.
She also made a detailed opening statement in support of her application, in which she said that the period since her name was removed from the Register was extremely difficult and also that she now unconditionally accepted all the Committee’s original findings in May 2021, some of which she had previously denied and had failed to acknowledge.
Dr Burrows went on to state that she only had herself to blame for her actions and that she now understood and accepted that the original sanction of removal from the register had needed to be severe given the serious breach of trust to the public, to the veterinary profession and the insurance industry that was a direct consequence of her dishonest actions.
Since removal from the Register, Dr Burrows had taken on the role of receptionist in a Vets4Pets practice in Cardiff, which required her to deal directly with the public and their insurance requests and entitlements.
She stated that as a result of her involvement over the past 18 months in processing insurance claims, she acknowledges the “delicate” relationship between veterinary surgeons, clients and insurers.
Additionally, working as a receptionist, had allowed her to recognise the need for contemporaneous and clear clinical notes.
She also highlighted her CPD, which was relevant to insurance, as well as the fact she’d undertaken a professional ethics course to assist her rehabilitation, reflection, and insight.
In support of Dr Burrows’ restoration to the Register, the Committee took into account three witness accounts from people who work at the Vets4Pets branch where Dr Burrows works as a receptionist.
All witnesses gave positive reflections on Dr Burrows’ character and assured the Committee that they would provide the correct level of support to allow her to return to work safely and that they would have all the necessary safeguarding measures in place to ensure that the public’s and the profession’s interest is always at the forefront.
Judith Way, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee was impressed by the fact that busy professionals chose to give up their time to provide witness statements and give evidence in support of Dr Burrows’ application.
"All witnesses were clearly supportive of Dr Burrows’ request for restoration to the Register.
“The Committee found Dr Burrows to show remorse and she does now accept the findings of dishonesty that were made against her in the original enquiry hearing and stated that her conduct was dishonest.
"In the Committee’s view, the evidence given by Dr Burrows on affirmation was very believable and she now accepts her dishonesty together with the gravity of her dishonesty.
“The Committee also formed the view that the steps she has taken to address her dishonesty serve to confirm that she is passionate about the prospect that she be allowed to return to practise.
"The Committee was impressed by Dr Burrows and the evidence given and is now satisfied that she will ensure the highest standards of probity and honesty in the future.
“Having taken all evidence into account, the Committee is satisfied that the future welfare of animals under Dr Burrows’ responsibility will be properly protected, and that her future dealings with insurers will be honest in all respects and that the interests of the public will be met.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Vetoquinol has made changes to Zentonil®, its liver support range for dogs and cats.
New Zentonil® is the UK's FIRST palatable and divisible tablet range of S-adenosyl-methionine (SAMe) supplementation and now comes with the added benefit of choice: Zentonil® Advanced which contains pure SAMe plus silybin and Zentonil® Plus which contains pure SAMe only.
A patent pending microencapsulation technique protects the SAMe from the harmful effects of stomach acid, even when the tablet is split or chewed.
The ability to split the tablets makes administration more accurate and also makes the product more cost-effective for clients.
Vetoquinol's new Zentonil® formulations have proven SAMe bioavailability curves in a market where this particular type of data is often lacking
Simon Boulton, product manager said: "Our customers told us that they had difficulties associated with SAMe supplementation. We have listened to their comments and provided the solutions."
The new formulations will become available as wholesalers' Zentonil® stocks are depleted. If you wish to try new Zentonil® now, you can place an order for Zentonil® Advanced or Zentonil® Plus with your wholesaler.
For more information, please contact your local Vetoquinol sales representative or telephone the free practice support number - 0800 1698197.
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
The awards are to recognise the work carried out by veterinary professionals.
Last year Petplan had a remarkable 37,000 nominations, for the five award categories: Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year.
James Barnes, head of sales & partnerships at Petplan, said: “For over two decades we’ve been recognising the brilliant work of the UK’s veterinary professionals. Every year the quality of entries is incredibly high but we know that during 2020 the profession really went the extra mile to take care of the nation’s pets so we expect the 2021 awards to be extra special.
To nominate a colleague or your practice, visit: https://www.petplanvet.co.uk/veterinary-practice-insurance/veterinary-awards before nominations close on 18th January 2021.
Avacta has announced the launch of Natural VetCare Prescribed, a new range of veterinary exclusive nutraceutical skin and joint supplements.
The range is manufactured in the UK by Natural VetCare and includes four products in total.
Avacta’s commercial manager, Hayley Booth, said: "Cani Flex is designed to support the body’s anti-inflammatory response with a powerful antioxidant formula, which rebalances the system by addressing excess free-radical build up around the joint following injury or wear and tear. Cani Flex Senior also targets joint, heart and brain health and encourages increased activity.
"With allergies becoming more and more prolific, Cani Skin and Feli Skin target one of the most complex issues facing vets and pet owners in today’s environment. The formulations are designed to resolve the body's hypersensitivity by balancing the immune response.
Hayley added: "To ensure veterinary exclusivity, the unique dispensing method has been thoroughly researched and trialed. The easy-to-feed sprinkle capsules sold in individual gold foil pouches are not for sale individually, and boxes of pouches are available direct from veterinary wholesalers only."
For more information, visit avactaanimalhealth.com/NVCPrescribed, contact your Avacta territory manager or call customer services on 0800 8494 550.
The survey was carried out by the Institute for Employment Studies (IES), which sent it to 5,572 veterinary surgeons who graduated from a vet school in the EU (excluding the UK) and who are registered as veterinary surgeons in this country, as well as around 100 non-UK EU-trained veterinary nurses.
The survey asked a range of questions about how these individuals felt that the vote to leave the EU had affected them, how they felt about their future working in the UK veterinary sector and how they felt the College had dealt with the issue of Brexit.
3,078 people (including 19 veterinary nurses) responded to the survey – a response rate of 55.3%. The average age of the respondents was 36. 60% were female and 87% were working full-time.
The largest group of respondents (22%) qualified in Spain. 14% qualified in Italy, 10% in Poland, 9% in Romania, 7% in Portugal, 6% in Germany and 6% in the Republic of Ireland.
The remaining 26% qualified in 18 different countries, each of which accounted for fewer than 5% of EU registrants. Although these figures relate to country of qualification and not the nationality of the individuals, in 91% of cases these were the same.
The majority of respondents (78%) worked in clinical practice. Of the 603 who did not work in clinical practice, 38% worked for the Food Standards Agency, 21% worked for the Animal and Plant Health Agency and 18% worked in higher education.
The main findings of the survey were:
RCVS President Chris Tufnell said: "This survey makes the strongest possible case that the Government must act fast to reassure our EU colleagues in practices, universities and industry that they are welcome to stay in the UK.
"EU vets and vet nurses make a massive contribution to the UK veterinary sector and the health and welfare of animals and humans.
"Beyond this commitment we will also be lobbying the Government that, after we leave the EU, suitably qualified vets from overseas are prioritised for UK work visas or equivalent, particularly if they are working in public health and the meat industry.
"I have written to Michael Gove, the new Secretary of State for the Environment, Food & Rural Affairs, outlining our position and our Brexit Principles and have invited him to visit the RCVS at Belgravia House to discuss these further. I hope that he accepts our offer so that we can have some constructive talks on these matters.
"On a personal note, I am very sorry to see that a significant proportion of respondents had experienced prejudice at work. This is simply not acceptable and we, as a regulator, have been conscious that ‘anti-foreigner’ rhetoric in the country at large could have an effect on hard-working and talented members of our profession, which is why we raised the matter in our letter to the Prime Minister last year."
The findings of interviews with a sample of non-UK EU-graduated veterinary surgeons working in the UK will be published over the summer. Meanwhile, over the next two years, IES will also be carrying out two further pieces of research that will track the opinions and intentions of non-UK EU-graduated veterinary surgeons and veterinary nurses over time as Brexit policies are formed and the future status of non-UK nationals made clearer.
To read the IES report and the College’s three Brexit Principles in full, visit www.rcvs.org.uk/brexit
Rexxolide contains 100 mg/ml of tulathromycin, which is widely used to treat BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, to make it more convenient.
Dechra says Rexxolide has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis.
Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.
"We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition."
Rexxolide is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.
Armed with the new microscope, New Forest Equine Vets (NFEV) has started offering a mobile equine veterinary service, including expert worming advice.
The microscope captures images with a resolution of 1 micron, with a live magnification of x200 and x400 or more, which means that the practice can carry out an accurate egg count in the yard, rather than sending faecal samples off to the lab.
This, they say, allows for a more a more accurate result, because posting faeces can lead to the sample desiccating and the eggs hatching, leading to false negative results. It also allows the veterinary surgeon to give immediate advice and treatment.
Dr. Beth Robinson BVSc Cert AVP(EP) MRCVS, co-owner of NFEV, says "One of the main aims of performing worm egg counts is to identify horses shedding low numbers of eggs so that we can maintain a low number of parasites on the pasture that have not been exposed to wormers and therefore have not been placed under selection pressure for resistance. In horses shedding high numbers of eggs, worm egg count reduction tests are a useful way of assessing whether treatment has been effective."
Andrew Monk, co-founder of ioLight, said: "The product is incredibly simple to use. By using a tablet both the owner and vet can view the image and discuss treatment. We hope that more horse owners in the New Forest will use the services from NFEV to protect their animals, and that it will encourage other equine practices to purchase a microscope so they can also offer a similar high quality service. We have made a video with NFEV to demonstrate their service and encourage other equine vets to use the ioLight microscope in their own mobile clinics."
Beth added: "We are delighted to be working with ioLight and horse owners to keep their animals healthy and improve equine welfare."
The Strategic Plan was developed throughout the course of 2016 with input from a number of stakeholders including RCVS Council and Veterinary Nurses Council, key committees and College staff. Most importantly, the evidence for change came from the wide and deep consultations that took place within Vet Futures, the joint RCVS and British Veterinary Association project that aims to help the veterinary profession prepare for and shape its future.
The other four ambitions described in the plan are:
Nick Stace, RCVS CEO, said: "The hallmark of our 2014 to 2016 Strategic Plan was getting the basics right by clarifying our identity, improving our core functions, setting out our service agenda and strengthening our foundations. The plan gave us a firm foundation to build upon and improved levels of confidence in the College from stakeholders which has allowed us to be more ambitious and outward-looking with this new plan.
"Within the new plan there are challenging ambitions and stretching objectives that address some of the big issues affecting the veterinary team, whether that’s playing a more global role post-Brexit, the importance of embracing new technology, or the pressing need to consider culture change within the profession to ensure it continues to grow and learn.
"I would ask each member of the profession to take a look at the Strategic Plan and I am very happy to receive comments and feedback on the plan by email at nick@rcvs.org.uk."
To download the Strategic Plan, visit www.rcvs.org.uk/publications
Daniel Calvo Carrasco, an RCVS specialist in Zoo and Wildlife Medicine and a European Specialist in Avian Medicine and Surgery, will be heading up the new service, which opens its doors to patients in January.
Daniel graduated from Universitat Autònoma de Barcelona in 2010. He began his career at first opinion practices in Birmingham and Wiltshire, where he developed his skills as a vet in small animals, while still having the chance to look after small furries from a local pet shop where he was based. He then completed an exotic animal medicine and zoological medicine internship, followed by two years of small animal and exotic practice in the UK.
In May 2016 he gained his RCVS CertAVP(ZooMed) and later that year he completed his European College Zoological Medicine Avian residency.
For the next two years, he worked at Great Western Exotics before joining the Wildfowl & Wetlands Trust in 2018, where he combined conservation work with managing and caring for its living collection.
Daniel said: “I’ve always had a passion for zoological medicine and caring for the more exotic mammals, birds, reptiles and amphibians, and I’m excited to be leading this new service at Southfields.
“I really enjoy all aspects of exotic, zoo and wildlife medicine and have a particularly keen interest in orthopaedics and advanced surgery in exotic species.
“I have treated all sorts of species in my time from parrots and lizards to wading birds such as the Spoon-billed Sandpiper, Aldabra tortoise, Hyacinth Macaw, Toucans, Seriemas and many birds of prey.”
Southfields hospital director Daniel Hogan said: “We are delighted to have recruited Daniel to lead this exciting addition to the services we offer.
“He is highly experienced and will lead our new exotic animal service, which is the first such service in the whole of the South East and will be available 24/7 to offer the best and most comprehensive zoo and wildlife care in the region.”
For more information, visit: https://www.southfields.co.uk/
Royal Canin is to launch a hepatic diet for cats.
Available from July 2011, Royal Canin Hepatic Feline is designed to provide nutritional support to the cat post-surgery and throughout a wide range of clinical conditions including cholangitis, cholestasis, portosystemic shunts, hepatic encephalopathy, liver failure and hepatic copper accumulation.
Royal Canin says the diet includes the use of highly digestible vegetable proteins which reduce the workload of the recovering liver; low copper levels to help reduce the risk to the liver of damage caused by copper and bile interaction; an exclusive antioxidant complex to neutralise free radicals, and balanced mineral levels to help counteract electrolyte imbalances caused by liver disease.
The company also says Royal Canin Hepatic Feline is 'outstandingly palatable', making it much easier for the cat (and the owner) to adhere to the regime.
Royal Canin Hepatic Canine is also available in both wet and dry versions. For more information, contact your Royal Canin Veterinary Business Manager, call 0845 717 800, or visit http://www.royalcanin.co.uk/.
Tri-Solfen contains lidocaine and bupivacaine to deliver rapid onset and prolonged local anaesthesia, adrenalin to reduce blood loss and cetrimide to lower the risk of infection.
Dechra says the gel is effective in 30 seconds, making it a practical tool to improve animal welfare via cutaneous and epilesional use.
Tri-Solfen was originally developed and launched in Australia by Medical Ethics, a company that specialises in pain management treatments for humans and animals.
According to the company, more than 100 million animals have been treated with Tri-Solfen in Australia, New Zealand and Portugal, where it is licensed for disbudding, dehorning, castration and general wound treatments in cattle, sheep, pigs and horses.
www.dechra.co.uk